Inhibitor Therapeutics, Inc. Shareholders' Equity
Inhibitor Therapeutics, Inc. (INTI) had Shareholders' Equity of -$2.56 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$2.56M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$1.98M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$1.29M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.45K.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$2.56M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$1.98M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | -$1.29M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $3.45K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $715.64K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $1.35M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $1.99M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $3.41M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $4.14M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $4.64M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $5.28M 10-K · filed 2026-03-26 | |
| 2023-09-30 | $6.45M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $7.11M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $7.76M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $8.30M 10-K · filed 2025-03-28 | |
| 2022-09-30 | -$4.02M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$3.90M 10-Q · filed 2023-11-13 | -$3.90M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$3.77M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | -$3.62M 10-K · filed 2024-03-29 | |
| 2021-09-30 | -$3.54M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$3.51M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | -$3.40M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$3.36M 10-K · filed 2023-03-31 | |
| 2020-09-30 | -$3.37M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$3.27M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | -$2.95M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | -$2.53M 10-K · filed 2022-03-30 | |
| 2019-09-30 | -$1.88M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | -$1.17M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | -$572.27K 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $32.35K 10-K · filed 2021-03-26 | |
| 2018-09-30 | -$2.68M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$1.64M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | -$822.42K 10-Q · filed 2019-11-07 | $1.54M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $166.56K 10-K · filed 2020-03-30 | |
| 2017-09-30 | $1.06M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $1.72M 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $2.38M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $7.03M 10-K · filed 2019-03-07 | |
| 2016-09-30 | $3.39M 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $4.30M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$322.79K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $423.98K 10-K · filed 2018-02-16 | |
| 2015-09-30 | $1.01M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $1.78M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$440.89K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $62.08K 10-K · filed 2017-02-17 | |
| 2014-09-30 | -$9.54K 10-Q · filed 2014-10-10 | |
| 2014-06-30 | -$153.35K 10-Q · filed 2014-08-13 | |
| 2014-03-31 | -$962.32K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$765.84K 10-K · filed 2016-02-01 | |
| 2013-09-30 | -$550.67K 10-Q · filed 2013-11-14 | |
| 2012-12-31 | -$132.78K 10-K · filed 2015-02-13 | |
| 2011-12-31 | -$369.15K 10-K · filed 2014-04-15 |